Literature DB >> 28985994

From mundane medicines to euphorigenic drugs: How pharmaceutical pleasures are initiated, foregrounded, and made durable.

Henry Bundy1, Gilbert Quintero2.   

Abstract

BACKGROUND: Examining how pharmaceuticals are used to induce pleasure presents a unique opportunity for analyzing not only how pleasure is assembled and experienced through distinct consumption practices but also how mundane medicines can become euphorigenic substances.
METHODS: Drawing on qualitative research on the non-medical use of prescription drugs by young adults in the United States, this paper utilizes Actor-Network Theory (ANT) to examine how prescription medicines come to produce pleasure.
RESULTS: Our research found an indeterminacy of experience as individuals were initiated into prescription drug pleasures. We also found that euphorigenic effects coalesce and are foregrounded through subsequent use, and that pleasure and other forms of gratification are made durable through repeated and deliberate pharmaceutical consumption.
CONCLUSION: Understanding how individuals are socialized into pharmaceutical pleasure, and how assemblages act to constitute the euphorigenic potential of pharmaceutical misuse, may allow for more context-appropriate intervention efforts. We suggest that the euphorigenic properties ascribed to prescription drugs are not inherent in their pharmaceutical formulations, but instead emerge through interactions within networks of heterogeneous actants.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Actor–Network Theory; Non-medical prescription drug use; Pleasure

Mesh:

Substances:

Year:  2017        PMID: 28985994      PMCID: PMC5681871          DOI: 10.1016/j.drugpo.2017.08.006

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  22 in total

1.  Drugs for life.

Authors:  Joseph Dumit
Journal:  Mol Interv       Date:  2002-06

Review 2.  Rethinking models of psychotropic drug action.

Authors:  Joanna Moncrieff; David Cohen
Journal:  Psychother Psychosom       Date:  2005       Impact factor: 17.659

3.  Development of opioid formulations with limited diversion and abuse potential.

Authors:  Paul J Fudala; Rolley E Johnson
Journal:  Drug Alcohol Depend       Date:  2006-03-24       Impact factor: 4.492

Review 4.  Affective neuroscience of pleasure: reward in humans and animals.

Authors:  Kent C Berridge; Morten L Kringelbach
Journal:  Psychopharmacology (Berl)       Date:  2008-03-03       Impact factor: 4.530

5.  Erasing pleasure from public discourse on illicit drugs: on the creation and reproduction of an absence.

Authors:  David Moore
Journal:  Int J Drug Policy       Date:  2007-08-28

6.  The pleasure in context.

Authors:  Cameron Duff
Journal:  Int J Drug Policy       Date:  2007-09-04

Review 7.  Issues in long-term opioid therapy: unmet needs, risks, and solutions.

Authors:  Steven D Passik
Journal:  Mayo Clin Proc       Date:  2009-07       Impact factor: 7.616

8.  Coming to our senses: appreciating the sensorial in medical anthropology.

Authors:  Mark Nichter
Journal:  Transcult Psychiatry       Date:  2008-06

9.  Patterns of drug use from adolescence to young adulthood: III. Predictors of progression.

Authors:  K Yamaguchi; D B Kandel
Journal:  Am J Public Health       Date:  1984-07       Impact factor: 9.308

10.  Risk for initiation of substance use as a function of age of onset of cigarette, alcohol and cannabis use: findings in a Midwestern female twin cohort.

Authors:  Arpana Agrawal; Julia D Grant; Mary Waldron; Alexis E Duncan; Jeffrey F Scherrer; Michael T Lynskey; Pamela A F Madden; Kathleen K Bucholz; Andrew C Heath
Journal:  Prev Med       Date:  2006-05-11       Impact factor: 4.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.